Thurston Springer Miller Herd & Titak’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$71.3K	Buy	1,465 +120	+9%	+$5.84K	0.01%	573
2025 Q1	$45.8K	Buy	1,345 +103	+8%	+$3.51K	0.01%	655
2024 Q4	$48.9K	Sell	1,242 -84	-6%	-$3.31K	0.01%	544
2024 Q3	$62.3K	Sell	1,326 -20	-1%	-$940	0.02%	507
2024 Q2	$72.7K	Buy	+1,346	New	+$72.7K	0.02%	473